Kiromic BioPharma has put 31 people on furlough. The cell therapy biotech has stopped paying the employees, which make up “substantially all” of its workforce, until it raises money to ease its cash ...

Incyte has delivered a pair of pivotal wins for an oral JAK inhibitor in an inflammatory skin condition. But with the placebo ...

Biotechnology has been in use by humans for over 10,000 years. Ancient bioscience incorporated processes like fermentation ...

The convergence of artificial intelligence (AI) with biotechnology has contributed to the development of therapeutics and ...

GreenLabs is collecting waste from Veolia customers to make waste storage bins at its injection molding site in Leominster, ...

The Cell-Based Assays Market is projected to grow from $35.3 billion in 2024 to $56.3 billion by 2029, at a 9.8% CAGR, driven by demand for drug discovery, ADME/toxicity testing, and precision ...

It looks like SoftBank's Vision Fund 2 is coming back strong. In the last nearly two quarters, the fund has participated in ...

Biotechnology has been in use by humans for ... However, given rapid advancements in gene editing technologies such as CRISPR, the scope of the Cartagena Protocol should be broadened to include ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Explore the promising potential of Altimmune, Inc.'s Pemvidutide in NASH, AUD, & obesity treatment, with key trials underway.